(Q68411779)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383962%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

title

Preclinical phase II studies in human tumor lines: a European multicenter study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383962%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

author name string

E Boven

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383962%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

B Winograd

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383962%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

O Fodstad

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383962%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

M W Lobbezoo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383962%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

H M Pinedo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383962%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

publication date

1 March 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383962%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer & Clinical Oncology

24 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383962%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383962%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383962%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

page(s)

567-573

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383962%20AND%20SRC:MED&resulttype=core&format=json

Is the P388 murine tumor no longer adequate as a drug discovery model?

24 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990039-6

7 January 2021

Validation of the clinical predictive values of the in vitro phase II clonogenic assay in cancer of the breast and ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990039-6

7 January 2021

Chemotherapy of human breast-carcinoma xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990039-6

7 January 2021

The human tumour xenograft—a valid model in experimental chemotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990039-6

7 January 2021

Correlation between response to chemotherapy of human tumors in patients and in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990039-6

7 January 2021

The response to chemotherapy of a variety of human tumour xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990039-6

7 January 2021

New methods for determining tumor sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990039-6

7 January 2021

Secondary screening of platinum compounds in human ovarian cancer xenografts in nude mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990039-6

7 January 2021

Superior efficacy of trimelamol to hexamethylmelamine in human ovarian cancer xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990039-6

7 January 2021

Chemotherapy of human head and neck cancer xenografts with three clinically active drugs: cis-platinum, bleomycin and methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990039-6

7 January 2021

Lack of effect of methotrexate on human head and neck tumours transplanted in athymic nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990039-6

7 January 2021

Development of three human small cell lung cancer models in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990039-6

7 January 2021

Response to chemotherapy of human, malignant melanoma xenografts in athymic, nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990039-6

7 January 2021

Effect of tamoxifen on the receptor-positive T61 and the receptor-negative T60 human breast carcinomas grown in nude mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990039-6

7 January 2021

Adriamycin. A new anticancer drug with significant clinical activity

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990039-6

7 January 2021

The anthracycline antineoplastic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990039-6

7 January 2021

Inhibition of pyrimidine de novo synthesis by DUP-785 (NSC 368390)

1 reference

https://api.crossref.org/works/10.1016%2FS0277-5379%2898%2990039-6

7 January 2021

10.1016/S0277-5379(98)90039-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383962%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference